7/30/2013 11:03:07 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
The diagnosis once again for Pfizer and Merck couldn’t be more different. Pfizer, with a plan to revamp its business and soaring profit, seems the image of fine health. At the same time, Merck is struggling with generic competition, and just watched its quarterly profit decrease by 50%.
Help employers find you! Check out all the jobs and post your resume.
comments powered by